Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. | Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. | Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. | |
Founding Date | Founding Date 1923 | Founding Date 1849 | Founding Date 2013 | Founding Date 1954 | Founding Date 1982 | Founding Date 1878 | Founding Date 1993 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations North Chicago, US HQ Alger, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | Locations Morris Plains, US HQ | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | |
Employees | Employees 14,754 | Employees 83,0005% increase | Employees 50,000 | Employees 38,117 | Employees 102 | Employees 4,959 | Employees 6,1712% increase | Employees 38,0003% increase |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 163.9 b | Valuation ($) 335 b | Valuation ($) 1.5 b | Valuation ($) N/A | Valuation ($) 12.3 b | Valuation ($) N/A | Valuation ($) 14 b |
Financial | ||||||||
Revenue (est.) | Revenue (est.) ¥1.6t (FY, 2024) | Revenue (est.) $58.5b (FY, 2023) | Revenue (est.) $54.3b (FY, 2023) | Revenue (est.) ¥586.8b (FY, 2024) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) ¥410.1b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $15.4b (FY, 2023) |
Cost of goods | Cost of goods ¥134.6b (FY, 2024) | Cost of goods $25b (FY, 2023) | Cost of goods $20.4b (FY, 2023) | Cost of goods ¥356.6b (FY, 2024) | Cost of goods N/A | Cost of goods ¥39.3b (FY, 2024) | Cost of goods N/A | Cost of goods $9b (FY, 2023) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit $33.5b (FY, 2023) | Gross profit $33.9b (FY, 2023) | Gross profit ¥230.2b (FY, 2024) | Gross profit $295k (FY, 2019) | Gross profit ¥395.8b (FY, 2024) | Gross profit N/A | Gross profit $6.4b (FY, 2023) |
Net income | Net income ¥17b (FY, 2024) | Net income $2.2b (FY, 2023) | Net income $4.9b (FY, 2023) | Net income ¥12.2b (FY, 2024) | Net income ($357.3m) (FY, 2019) | Net income ¥160.6b (FY, 2024) | Net income N/A | Net income $54.7m (FY, 2023) |
Operating ⚠ | ||||||||
Countries | Countries N/A | Countries 125 (FY, 2021) | Countries 70 (FY, 2022) | Countries N/A | Countries N/A | Countries N/A | Countries 126 (Jan, 2021) | Countries 165 (Q1, 2023) |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 19 (FY, 2022) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 4 (FY, 2018) | Manufacturing Facilities 36 (Jan, 2021) | Manufacturing Facilities N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 39 (FY, 2021) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) |
Patent Applications (US) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 230 (Sep, 2022) | Patent Applications (US) N/A | Patent Applications (US) 23 (Jan, 2021) | Patent Applications (US) N/A |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 405 (Sep, 2022) | Patents (US) N/A | Patents (US) 38 (Jan, 2021) | Patents (US) N/A |
Product Categories | Product Categories N/A | Product Categories N/A | Product Categories 6 (FY, 2022) | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories 3 (Q1, 2023) |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 200 (Jan, 2021) | Products 4 (FY, 2022) |
Funding | ||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised N/A |